Is Cullinan Therapeutics, Inc. (CGEM) a Buy, Sell, or Hold?
NASDAQ : CGEM
Cullinan Therapeutics, Inc. — Competitors
$19.46 USD
$1.18 (6.46%)
- Volume
- 346.72K
- Average Volume
- 933.5K
- Market Capitalization
- $1.2B
- P/E Ratio
- -5.77
- Dividend Yield
- 0.00%
- Price Target
- $33.50
- Year High
- $19.55
- Year Low
- $5.68
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.42
CGEM vs. The Competition
| Properties | CGEM | ADCT | BCYC | CBLL |
|---|---|---|---|---|
| Market Cap | $1.2B | $146.27M | $287.29M | $806.24M |
| Shares Outstanding | $61.46M | $127.19M | $69.39M | $37.94M |
| P/E Ratio | -5.77 | -1.09 | -1.52 | -12.07 |
| EPS | -3.33 | -0.89 | -2.73 | -1.74 |
| Day Low | 18.35 | 1.11 | 4.09 | 18.87 |
| Day High | 19.55 | 1.15 | 4.15 | 21.33 |
| Year Low | 5.68 | 0.78 | 3.745 | 10.85 |
| Year High | 19.55 | 4.98 | 9.159 | 24.33 |
| Average Price 50 | 16.633 | 1.31848 | 4.1368 | 18.5206 |
| Average Price 200 | 13.33138 | 3.25297 | 5.47825 | 18.6518 |
| Volume | 346.72K | 131.09K | 58265.04 | 996.26K |
| Average Volume | - | - | - | - |